Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9845291 Estrogen receptor modulators and uses thereof

Patent 9845291 was granted and assigned to Genentech on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9845291

Date of Patent

December 19, 2017

Patent Application Number

14972333

Date Filed

December 17, 2015

Patent Citations Received

‌

US Patent 11993608 Selective estrogen receptor degraders

‌

US Patent 11713296 Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-l-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate and preparation process thereof

‌

US Patent 11857518 Methods for treating cancer

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

Described herein are compounds that are estrogen receptor modulators of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9845291 Estrogen receptor modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API